Ebitda Alterar Data
Amarin USD 12.54M 28.57M 2025-06
Ardelyx USD -29.77M 35.79M 2026-03
Baxter International USD 309M 756M 2026-03
Bayer EUR 2.14B 2.31B 2026-06
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Biogen USD 649.7M 76.5M 2026-03
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Gilead Sciences USD 3.51B 489M 2026-03
GlaxoSmithKline GBP 3.51B 734M 2026-06
Halozyme Therapeutics USD 328.81M 109.24M 2026-06
Insmed USD -148.3M 165.88M 2026-03
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
J&J USD 8.27B 1.08B 2026-03
Lexicon Pharmaceuticals USD -12.04M 15.95M 2025-09
Moderna USD -1.26B 468M 2026-03
Omeros USD -47.96M 7.39M 2023-09
Pfizer USD 6.01B 18M 2026-06
PTC Therapeutics USD 61.98M 132.97M 2026-03
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Sarepta Therapeutics USD 375.48M 627.68M 2026-03
Teva Pharmaceutical Industries USD 474M 581M 2026-06
United Therapeutics USD 355M 11.1M 2026-06
Vertex Pharmaceuticals USD 1.33B 130.5M 2026-06